Skip to main content

Publications

featured publications

  • Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors.

    Clinical & translational immunology

    Authors: Jonas Saal, Jörg Ellinger, Manuel Ritter, Peter Brossart, Michael Hölzel, Niklas Klümper, Tobias Bald

  • Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancer.

    Frontiers in immunology

    Authors: Annkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, Chrystel Flores, Peter Brossart

  • Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU).

    Hematology (Amsterdam, Netherlands)

    Authors: Michael Serries, Hannah Zenzen, Mario Heine, Tobias Holderried, Peter Brossart, Katjana Schwab

  • Optimized Conformal Total Body Irradiation with VMAT Using a Linear-Accelerator-Based Radiosurgery Treatment System in Comparison to the Golden Standard Helical TomoTherapy.

    Cancers

    Authors: Mümtaz Köksal, Oğuzhan Özkan, Tobias Holderried, Annkristin Heine, Peter Brossart, Ahmed Gawish, Davide Scafa, Gustavo R Sarria, Christina Leitzen, Leonard C Schmeel, Thomas Müdder

  • Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.

    Clinical chemistry

    Authors: Dimo Dietrich, Simone Weider, Luka de Vos, Timo Jakob Vogt, Moritz Färber, Romina Zarbl, Alina Hunecke, Ann-Kathrin Glosch, Jennis Gabrielpillai, Friedrich Bootz, Franz-Georg Bauernfeind, Franz-Josef Kramer, Glen Kristiansen, Peter Brossart, Sebastian Strieth, Alina Franzen

  • Psoriatic arthritis or osteoarthritis? Data from a specialized dermatological-rheumatological collaboration-the Psoriatic Arthrtis Center Bonn.

    Journal of the European Academy of Dermatology and Venereology : JEADV

    Authors: Jana Schäfer, Charlotte Behning, Peter Brossart, Thomas Bieber, Dagmar Wilsmann-Theis, Valentin Sebastian Schäfer

  • CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.

    Clinical epigenetics

    Authors: Friederike Hoffmann, Alina Franzen, Luka de Vos, Lennert Wuest, Zsófi Kulcsár, Simon Fietz, Alexander Philippe Maas, Sarah Hollick, Marie Yatou Diop, Jennis Gabrielpillai, Timo Vogt, Pia Kuster, Romina Zarbl, Joern Dietrich, Glen Kristiansen, Peter Brossart, Jennifer Landsberg, Sebastian Strieth, Dimo Dietrich

  • Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma.

    JAMA oncology

    Authors: Jonas Saal, Tobias Bald, Markus Eckstein, Damian J Ralser, Manuel Ritter, Peter Brossart, Viktor Grünwald, Michael Hölzel, Jörg Ellinger, Niklas Klümper

  • Hospital sanitary facilities on wards with high antibiotic exposure play an important role in maintaining a reservoir of resistant pathogens, even over many years.

    Antimicrobial resistance and infection control

    Authors: Claudio Neidhöfer, Esther Sib, Marcel Neuenhoff, Oliver Schwengers, Tobias Dummin, Christian Buechler, Niklas Klein, Julian Balks, Katharina Axtmann, Katjana Schwab, Tobias A W Holderried, Georg Feldmann, Peter Brossart, Steffen Engelhart, Nico T Mutters, Gabriele Bierbaum, Marijo Parčina

  • The role of autoimmunity and autoinflammation in giant cell arteritis: A systematic literature review.

    Autoimmunity reviews

    Authors: Valentin S Schäfer, Peter Brossart, Kenneth J Warrington, Christian Kurts, Georg W Sendtner, Clemens A Aden